Presentation TCT 2018

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

September 21, 2018

REGISTER for free or LOG IN to view this content

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Structural Heart

Presentation

TCT 2018

Aortic Valve

Up Next

Presentation TCT 2018

Featured Lecture #2: Democratizing Clinical Excellence: Combining Digitized Patient Data and Guideline-Directed Best Practice

Presenter: Lonny Reisman

September 21, 2018

More slides +

Presentation TCT 2018

The Methods for Translational Mitral/Tricuspid Valve Development

Presenter: Michael J. Mack

September 21, 2018

Presentation TCT 2018

After the ATTRACT Trial: Which Patients With Acute Deep Vein Thrombosis Should Receive Endovascular Therapy?

Presenter: Teresa L. Carman

September 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.